Still a long way to go
12/07/24 -"We have huge doubts that FRE25 will achieve the planned profitability (group adjusted EBIT: 10-14%) by 2025 as there are numerous obstacles. The management has already indicated that the effects of ..."
Pages
57
Language
English
Published on
12/07/24
You may also be interested by these reports :
11/02/26
4Q sales increased 12.1% YoY (18.4% at constant currency) to €7.6bn, mainly driven by strong growth in AI glasses. However, this category continues ...
10/02/26
Philips’ Q4 results exceeded expectations, with comparable sales growth driven by strong performance in Personal Health and healthy contributions ...
06/02/26
Coloplast delivered a weak Q1, with both revenue and adjusted EBIT missing consensus. Organic growth of 6% was in line with expectations, but ...
06/02/26
Qiagen’s Q4 results surpassed both market expectations and management’s guidance, with most segments reporting gains. The 2026 guidance aligns with ...